BioLineRx’s EDP-14, for Treatment of Severe and Persistent Asthma, to Enter … – MarketWatch (press release)

BioLineRx's EDP-14, for Treatment of Severe and Persistent Asthma, to Enter …
MarketWatch (press release)
BL-9010, a novel bi-specific antibody treatment for severe and persistent asthma, targets and links together two immunological modulators – IgE and CD300a. Allergen-bound IgE activates cells involved in allergic responses, such as mast cells, while …
BIOLINERX LTD. : BioLineRx's EDP-14, for Treatment of Severe and Persistent …4-traders (press release)

all 2 news articles »